Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant zoledronic acid in high-risk giant cell tumour of bone
2008-005841-50Phase 2Active
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of zoledronic acid in Giant Cell Tumor of Bone (GCTB) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: 2-year recurrence rate. Started Oct 2008; status: active.
02
Drugs
zoledronic acid
03
Conditions
Giant Cell Tumor of Bone (GCTB)
Beyond the preview
Go deeper on 2008-005841-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005841-50.